New Data from Ambry Genetics Showed Concurrent RNA and DNA Testing Identified More Patients with Hereditary Breast Cancer than DNA Testing Alone -…

ALISO VIEJO, Calif., Dec. 10, 2019 /PRNewswire/ --Researchers atAmbry Genetics(Ambry), a leading clinical genetic testing lab, will announce new data showing that conducting RNA and DNA tests for hereditary cancer risk at the same time identifies more patients with mutations that increase cancer risk than DNA testing alone. To be presented at the San Antonio Breast Cancer Symposium (SABCS) this week, the data come from a study of 746 patients with breast cancer that received +RNAinsight, paired RNA and DNA genetic testing for hereditary cancer risk.

Standard DNA testing for hereditary cancer risk excludes large portions of DNA, thereby missing some mutations. In addition, DNA testing can produce inconclusive results and fail to determine that an error in our DNA increases cancer risk. These limitations impact patients and their families because doctors may not have the information needed to recommend appropriate preventive, early detection, or therapeutic steps. Additionally, relatives may not be referred for genetic testing and obtain the care they would otherwise have gotten if they had learned they had mutations.

Adding RNA to DNA testing overcomes these limitations for a substantial number of patients as it provides considerably more evidence than DNA testing alone about whether our DNA has mutations.

The data showed that adding RNA genetic testing to DNA testing increased the diagnostic yield the number of people found to have a mutation that increases cancer risk across 16 hereditary breast and/or ovarian cancer genes. As a result of +RNAinsight, five breast cancer patients were identified to have mutations in clinically-actionable genes that would have otherwise been missed completely or the patient would have received inconclusive results if they had received DNA testing only. These findings included three women with mutations in BRCA1/2, one woman with a mutation in ATM, and one woman with a mutation in PMS2. Additionally, paired RNA and DNA genetic testing decreased the number of inconclusive results, giving patients more definitive answers about whether their breast cancers were hereditary. Additional results will be presented on an expanded breast cancer cohort at the meeting on Saturday, December 14th.

"These data further prove that paired RNA and DNA genetic testing for hereditary cancer should be the industry standard," said Holly LaDuca, MS, CGC, senior manager of Ambry's clinical affairs research. "Our research has consistently shown that +RNAinsight provides clinicians with more accurate results, better informing patient care."

Researchers from Ambry will also present at SABCS new data from a pre-and post-test clinician survey that assessed how genetic testing for hereditary cancer impacted medical management, such as screening recommendations. The survey found that positive genetic testing results frequently lead to changes in management recommendations in both high risk (e.g. BRCA1) and moderate risk (e.g. ATM) genes. Changes to mammogram, breast MRI, and/or preventive surgery options were reported in 77.3% of positive individuals. Moreover, medical management changes largely adhered to published guidelines, indicating that cliniciansare applying recommendations appropriately based on test results.

"With this survey data, clinicians are showing us that they truly do use genetic testing results to implement personalized recommendations, which can be life-saving for a patient," said Carrie Horton, MS, CGC, senior researcher in Ambry's clinical affairs team. "These data provide further evidence that genetic testing is essential to comprehensive cancer care. Continued study in this area will aid clinicians, laboratories, health plans, and ultimately patients."

Below are summaries of each of the four studies that Ambry will present at SABCS 2019.

Friday, December 13, 5:00- 7:00 PM CST

P5-07-06,Black M, et. al., Performance of Polygenic Risk Score Combined with Clinical Assessment for Breast Cancer Risk

Saturday, December 14, 7:00 9:00 AM CST

P6-08-35,Horton C, et. al., Impact of Multigene Panel Testing on Medical Management: Preliminary Results of a Pre- and Post- Test Clinician Survey

P6-08-08,LaDuca H, et. al., Concurrent DNA and RNA Genetic Testing Identifies More Patients with Hereditary Breast Cancer than DNA Testing Alone

P6-08-04,Yadav S, et. al., Germline Mutations in Cancer Predisposition Genes in Patients with Invasive Lobular Carcinoma of the Breast

ABOUT AMBRY GENETICS

Ambry Genetics, as part of Konica Minolta Precision Medicine, excels at translating scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind genetic disease. Our unparalleled track record of discoveries over 20 years, and growing database that continues to expand in collaboration with academic, corporate and pharmaceutical partners, means we are first to market with innovative products and comprehensive analysis that enable clinicians to confidently inform patient health decisions. We care about what happens to real people, their families, and the people they love, and remain dedicated to providing them and their clinicians with deeper knowledge and fresh insights, so together they can make informed, potentially life-altering healthcare decisions. For more information, please visitambrygen.com.

For more information on risk factors for hereditary cancer, please visit cancer.gov's fact sheet on hereditary cancer and genetic testing.

ABOUT +RNAINSIGHT

+RNAinsight, paired with Ambry Genetics' hereditary cancer DNA tests, uses next-generation sequencing to concurrently analyze a patient's DNA and RNA, another layer of genetic information. +RNAinsight identifies more patients who have mutations that increase their cancer risks than through standard DNA-only testing by overcoming limitations of DNA testing. +RNAinsight enables more accurate identification of patients with increased genetic risks for cancer, finds actionable results that may otherwise be missed, and decreases the frequency of inconclusive results. +RNAinsight is now available through doctors and genetic counselors around the country. For more information on +RNAinsight, please go toambrygen.com/RNAinsight.

Press Contact:Liz Squirepress@ambrygen.com (202) 617-4662

View original content:http://www.prnewswire.com/news-releases/new-data-from-ambry-genetics-showed-concurrent-rna-and-dna-testing-identified-more-patients-with-hereditary-breast-cancer-than-dna-testing-alone-300972165.html

SOURCE Ambry Genetics

See the original post here:
New Data from Ambry Genetics Showed Concurrent RNA and DNA Testing Identified More Patients with Hereditary Breast Cancer than DNA Testing Alone -...

The Swedish Royal Family Wore Dazzling Tiaras to the Nobel Prize Ceremony – TownandCountrymag.com

JONATHAN NACKSTRANDGetty Images

Every year, members of the Swedish royal family gather for Nobel Prize Award Ceremony and banquet, honoring the 2019 Nobel laureates awarded the prizes in physics, chemistry, physiology or medicine, and literature in Stockholm, Sweden. (The Nobel Peace Prize is awarded in Oslo, Norway, and the Norwegian royal family hosts that ceremony).

The Swedish royal family goes all-out for the occasion with King Carl XVI Gustaf and Queen Silvia in attendance, along with Crown Princess Victoria and her husband Prince Daniel, Princess Madeleine, and Prince Carl Philip with Princess Sofia. The royal ladies traditionally wear sparkling tiaras and formal gowns fo the event, for added dazzle.

Last year, Silvia wore one of her favorite tiaras, the stunning Queen Sophia tiara, with a diamond and emerald necklace that perfectly coordinated with her green gown. Crown Princess Victoria, who is the heir to the Swedish throne, made a statement in the Connaught 'Forget-me-not" tiara, a diamond topper with circular detailing. Sofia went with pearls for her jewelry look, wearing the diamond and pearl Palmette tiara with a matching pearl choker.

Here, we've rounded up the standout tiaras as seen at the Nobel Prize Award Ceremony in Stockholm today:

Advertisement - Continue Reading Below

Queen Silvia and Crown Princess Victoria

Silvia chose a gown with intricate gold detailing, while Victoria opted for a black off-the-shoulder style. Both royals wore tiaras.

Queen Silvia

Silvia wore one of her favorite tiaras, the Queen Sophia tiara, which is also called the Nine Prong tiara,. Silvia also wore it to last year's Nobel Prize ceremony.

Crown Princess Victoria

Victoria wore the sparkling Baden fringe diamond tiara, paired with a diamond necklace and the Braganza Rose diamond brooch.

Princess Sofia and Princess Madeleine

Princess Sofia arrives at the ceremony with Princess Madeleine. Madeleine, who did not attend the Nobel Prize ceremony last year, wore a pink gown and an aquamarine tiara.

Princess Sofia

Sofia went for an all-blue ensemble, wearing a blue off-the-shoulder gown with her diamond wedding tiara, which was accented by new blue stones. The stones appear to be turquoises.

Princess Sofia

On her wedding day, Sofia's tiara was set with emeralds, but she has swapped out those stones on a few occasions. The Princess has replaced the stones with pearls in the past, like at the Nobel Prize ceremony in 2017 and 2018.

Princess Sofia

Another look at Sofia's tiara.

Princess Madeleine

Madeleine chose the Swedish Aquamarine Kokoshnik tiara, which once belonged to Princess Margaretha. The stunning diamond piece has been worn by Madeleine before, and by Crown Princess Victoria wore the tiara to the 2017 Nobel Prize Awards, per the Court Jeweller.

Princess Madeleine

A full look at her pink ensemble.

Princess Madeleine

Madeleine also wore dazzling diamond earrings and a matching bracelet with her tiara and sash.

Princess Madeleine

Another view of Madeleine's tiara at the Nobel Prize banquet.

Queen Silvia

Silvia's stunning brooch is on display as she arrives at the Nobel Prize banquet.

Princess Sofia

A look at Sofia's coordinating turquoise earrings, which perfectly match her tiara.

Princess Sofia

The new blue stones on the top of Sofia's diamond tiara were front and center as the royal sat during the Nobel Prize banquet.

Princess Madeleine

Another look at Madeleine's tiara.

Crown Princess Victoria

Victoria dazzled in the Baden fringe tiara.

Advertisement - Continue Reading Below

Originally posted here:
The Swedish Royal Family Wore Dazzling Tiaras to the Nobel Prize Ceremony - TownandCountrymag.com

Is the end of animal testing in sight? – E&T Magazine

Images of monkeys undergoing experiments in a German laboratory stirred a wave of public outrage recently, prompting questions whether such barbaric procedures are necessary in the 21st century. Technology exists today that could replace animal testing in the future, but how far is it from practical use?

In 2018, a team of Oxford University researchers announced that their computer models of human heart cells were able to predict side effects of various medications on the heart more accurately than animal studies.

While studies done on animals assessed the risk of arrythmias in human users with the accuracy of 75-85 per cent, the computer model of actual human heart cells made a correct prediction in 89-96 per cent of cases. That means that drugs could pass the animal tests but still later cause dangerous heart problems in patients, while this risk is lower when using computer models.

We took 62 drugs such as painkillers, antihistamines or antibiotics, many of which are on the market, and we looked for biomarkers indicating the risk of arrhythmias in our simulations, says Elisa Passini, a senior researcher in the Computational Cardiovascular Science team at the University of Oxford and the lead author of the paper published in the journal Frontiers in Physiology. Then we compared our results with what is known about these drugs. For example, there are reports of patients who have had a cardiac episode while taking these drugs. We compared our results with these reports and thats how we calculated the accuracy.

Passini says the difference in favour of the human heart cells computer model might arise because animal cells and organs, while having been widely used in drug development for decades, are in many ways similar to but by no means identical to human organs and cells.

Sometimes you dont see an effect in animals and then, if you give the drug to a human being, you will see an adverse effect on the heart, she adds.

In fact, according to a 2009 paper by Yale University epidemiologist Michael B Bracken, which was published in the Journal of the Royal Society of Medicine, there have been many cases in the past when drugs deemed safe in animal studies in fact caused serious harm once introduced to humans.

For example, thalidomide, a drug sold in the late 1950s and early 1960s as a sedative and treatment for morning sickness for pregnant women caused the foetuses to develop serious defects. Such side effects were not observed in animal studies.

A 2006 UK-based phase I clinical study of am immunomodulatory drug called TGN1412 (theralizumab), designed to alleviate symptoms of autoimmune diseases, caused life-threatening side-effects to all of the six previously healthy human volunteers enrolled in the study who were given the drug. Although they received doses 500 times lower than what had been found safe in animal studies, the human subjects quickly developed multi-organ failures and required lengthy hospitalisation. The drug had previously successfully passed tests not only in mice but also in rhesus monkeys, which up until then had been considered very similar to humans in their physiology.

Hazel Screen, a professor of biomedical engineering at Queen Mary University of London (QMUL), says that despite decades of use and refinement, the success rate in drug development based on the current animal models is extremely low.

Today, if something goes into clinical trials because it worked in animal models, the likelihood of it coming off is terrible, says Screen, who co-leads a project developing organ-on-a-chip technology another alternative that could replace animal tests in the future.

It currently takes approximately 14 years to develop a drug and only about 5 per cent of drugs actually end up being used to treat patients, she says.

Screen agrees with Passinis statement that one of the reasons for such a poor outcome is the fact that the cells, bodies and physiological processes of animals, while in many ways similar, simply do not perfectly match those of humans.

Screens colleague Professor Martin Knight says big pharma companies, hoping to improve this abysmal success rate, are looking for alternative technologies to at least partially replace animal tests.

Big pharma companies are primarily interested in increasing profits by getting better benefits for patients, rather than reducing animal testing per se, Knight says. They want to be able to predict more accurately whether these drugs are going to work and make sure that they progress more efficiently through the development pipeline.

According to the UK Home Office, 3.52 million scientific procedures were carried out in 2018 in the UK involving living animals, with mice, rats and fish making up 93 per cent of the total number.

The amount, the Home Office said, decreased by 7 per cent compared to 2017. Of the total amount, 1.80 million procedures were for experimental purposes, focusing on basic research, the development of new treatments, safety testing of pharmaceuticals, surgical training and education. The rest focused on the creation and breeding of genetically altered animals.

The cost of these experiments is substantial, especially since regulators, pressured by the 21st-century animal-rights-conscious public, require the scientists to improve conditions and minimise pain and suffering of the creatures used.

Many pharma companies are interested in the in-silico simulations of the Oxford University team, according to Passini. The team, which is part of the EU-funded Compbiomed initiative, has developed a software called Virtual Assay, which can run on a regular laptop and complete a simulation of 100 human heart cells interacting with a certain drug in about five minutes.

Our models are built on data from human patients, says Passini. Its usually patients that have gone through some surgery during which the doctors removed some cells, which were further studied. We also use data from healthy hearts that were not suitable for transplantations. The models are based on a large number of equations that represent what we know about the cardiac cells, their behaviour, their membranes, and the transport of ions in and out of cells.

These models, Passini says, are now quite ready to replace the early stage so-called in-vitro experiments experiments conducted on animal cells or small tissue samples.

We hope that our technology could in the not so distant future replace most of the in-vitro experiments, she adds. That would already make a huge difference because very large numbers of animals are used for these early stage experiments. The scientists kill the animals and take their cells. A much smaller number of animals is used for the later-stage in-vivo experiments.

The Oxford team can already run 3D simulations of an entire human heart. The availability of computational power, or lack thereof, is, however, the major stumbling block for this type of complex simulation.

We have access to some of the most powerful supercomputers in Europe, but it still takes hours to simulate a single heartbeat in 3D, Passini adds. We can afford to do this for scientific purposes, but the availability of such computer power is still limiting the use of these simulations by the industry. We are exploring alternatives, such as GPUs, which might make it more affordable in the future.

The Compbiomed project, which has recently concluded its first stage, has the ultimate goal of creating the entire human organism in silico that could be used for drug testing and simulations of various health conditions.

QMULs Knight says that the organ-on-a-chip technology could in the future reduce the number of mice, the most commonly used animal species in medical research, needed at certain stages of the drug development process. But for that to happen, the alternative technologies have to be validated and proved as reliable (if not more) as the currently used animal models.

The regulatory authorities are understandably going to be nervous about accepting results entirely from a completely new technology compared to using a set of well-established, if not always very accurate, animal models, Knight declares.

For them to accept new technologies, such as organ-on-a-chip, you have to prove that your liver, lung or gut model works in every imaginable set-up. Thats a lot of science and validation and confirmation before you reach that point.

Organ-on-a-chip systems use living human cells in a 3D device to mimic how human organs function. These devices can be used to test both the safety and efficacy of new medicines and other products, reducing the dependency on animal experiments. Usually the size of a 50-pence coin, chips already exist simulating human liver, lung and intestine.

Creating an environment that would simulate, as closely as possible, the environment in which the cells exist in the human body is the greatest engineering challenge facing the researchers.

Its become clear recently that mechanical forces have a huge impact on cell biology and therefore on how drugs behave, says Knight. Therefore, we need to make sure that the model systems that are being developed incorporate the right mechanical forces that the different tissues experience. For example, a model of the lung has to incorporate stretching as you inflate your lung; it has to incorporate the flow of air over the surface of the cells of the lung and the flow of blood in the blood vessels. And only by incorporating these key mechanical stimuli can we hope to generate a model that is truly predictive of how a drug is to behave in a body.

Last year, QMUL received a grant from Research Councils UK to lead a network that aims to bring together the UK research community in order to advance organ-on-a-chip development and cooperate with regulators and industry on validating the technology so that it can be rolled out on a larger scale.

While the complete end of animal experiments in medical science may be decades away, the researchers are positive that with the introduction of already existing technologies, their validation and further improvement, the numbers of animals required for the advancement of science will be gradually but significantly reduced over the coming decades.

Sign up to the E&T News e-mail to get great stories like this delivered to your inbox every day.

View post:
Is the end of animal testing in sight? - E&T Magazine

UVA, UVA-Wise Land Three Professors Among State’s Top 12 for 2020 – University of Virginia

The three University of Virginia professors named 2020 Outstanding Faculty Award winners Friday by the State Council of Higher Education for Virginia push the boundaries of the typical classroom and of their academic disciplines, employing hands-on experiences for students and conducting game-changing scholarship to aid humanity.

Arthur Weltman, professor and founding chair of the Department of Kinesiology in the Curry School of Education and Human Development, also holds UVAs 2019-21 Cavaliers Distinguished Teaching Professorship. Kirsten Gelsdorf, a professor of practice in the Frank Batten School of Leadership and Public Policy, came to UVA after working for the United Nations for two decades. Ryan Huish, an associate professor of biology at UVAs College at Wise, takes students of all ages outside, making the surrounding natural world their classroom and market.

Since 1987, the SCHEV awards have recognized faculty at Virginias institutions of higher learning who exemplify the highest standards of teaching, scholarship and service.Among the 12 awardees from Virginias colleges and universities, UVAs trio will be recognized for exemplifying the highest standards of teaching, scholarship and service at a March 9 ceremony in Richmond. Each will receive $7,500 from Dominion Energy, co-sponsor of the faculty awards.

A closer look at the awardees:

Gelsdorf was one of two professors SCHEV recognized as a Rising Star for early career achievements. Although she has only been on UVAs faculty for 3 years, she has already won teaching awards from Batten and from the University, as well as received perfect course-evaluation ratings from students.

The demand for her class, Global Humanitarian Crises, a 40-student seminar, skyrocketed to more than 200 students. She also piloted Battens first remote synchronous learning course to include students from UVAs College at Wise.

One student mentioned that Gelsdorfs weekend-long humanitarian crisis simulation required a higher level of thinking than any other college assignment he had undertaken. This experience encapsulates Professor Gelsdorfs desire to push us as students, to help bridge the gap between the theoretical and the practical, the student wrote.

As a professor of practice, Gelsdorf brings two decades of professional experience in United Nations programs to the University to bridge the academic-practitioner divide and influence policy change, activities that have operated on isolated tracks for too long, she wrote.

The field of global humanitarian aid, which has defined my lifes work, rests on the principle of the humanitarian imperative that people have the right to give and receive aid, she wrote. Through her scholarship and teaching, Gelsdorf aims to help expand and strengthen research and partnerships on Grounds and around the world that can influence policy change.

It is my clear responsibility to bring the questions of global humanity to this next generation.

- Kirsten Gelsdorf

The world will increasingly face unanswered questions and intractable challenges that result from conflict and disasters happening around the world. That is why I am so thankful that Batten and its leadership and public policy mission give me the unique opportunity to combine research and policy engagement into a portfolio where I can build partnerships between incredible faculty, students and external organizations to work on the humanitarian issues I care so deeply about, Gelsdorf wrote in an email after hearing she had won the award.

As Battens director of humanitarian policy, she has undertaken numerous high-level research and policy projects with organizations like the Red Cross, Global Emergency Groupand United Nations.

Together with other Batten faculty, she is now launching a series of research and policy labs that include work on early childhood education in crisis contexts and predictive analytics for migration that are being launched this month in London and at the Global Refugee Forum in Geneva.

This year, she also published with Daniel G. Maxwell, a colleague at Tufts University, Understanding the Humanitarian World, a book that traces the development of the modern humanitarian aid system and has already been adopted by numerous universities and international organizations.

An associate professor of biology at UVAs College at Wise, Huish specifically focuses on ethnobotany, the study of human-plant interactions.

He encourages student-centered learning in the classroom in novel ways. For example, in his General Botany course, he has asked his students to choreograph and perform an interpretive dance on the process of photosynthesis, one of the most important biochemical reactions to life on Earth, yet a very complex and difficult process to grasp.

Writing about his love for plants, which he links to his earliest memories, Huish wrote in a teaching statement, The beautiful complexity of photosynthetic organisms is what originally filled our early atmosphere with life-sustaining oxygen by splitting water molecules; sparked the dawn of modern human civilization in the Fertile Crescent with agriculture; initiated globalization with the spice trade; solicited trade wars; manufactured compounds that humans converted to pharmaceuticals and the list of connections goes on.

His passion for plants and dedication to teaching everyone to love and respect plants was so inspiring it changed my whole career path, wrote Jenni Gilliam, a former student whos an intern at the Center for Appalachian Studies.

He doesnt just teach the biology of plants to undergraduate students; he also teaches younger students and adult community members about local edible plants, plus medicinal or economic possibilities with plants.

He learns from them, too, and is currently interviewing community members to preserve not only Appalachian traditional uses and folklore, but also to work toward preserving the native plants and their habitats.

He has conducted medical botany research in the South Pacific Islands, working with local people of the Tonga islands. In addition, he leads a UVA-Wise team working with a Tongan plant that potentially could prevent the effects of MRSA, an antibiotic-resistant super bug becoming more common in hospitals.

My passion is to help others comprehend at even some small level, the vast beauty, potential and complexity of these humble yet magnificent organisms.

- Ryan Huish

Closer to home, Huish is also researching the potential of hemp to replace tobacco farming and the development of maple syrup as a product. He and his students share their knowledge with the community, and he has led a tour of his own farm to show methods of woodland management. He is collaborating with the regional nonprofit organization Appalachian Sustainable Development and Virginia Tech in the Appalachian Beginning Forest Farmer Coalition.

I am grateful and honored to have received this award, Huish wrote in an email. I feel that this award reflects the greater good and the strengths of UVA-Wise, which espouses the liberal arts paradigm of applying deep interdisciplinary collaboration and societal connections to problem-solving. I am proud that we emphasize the well-rounded development of these skills in our students and faculty for real and meaningful progress.

Arthur Weltman was awarded the 2019-21 Cavaliers Distinguished Teaching Professorship earlier this year, an endowed chair that recognizes an eminent scholar for outstanding and enduring excellence in the teaching of undergraduates.

During his 35 years at UVAs Curry School of Education and Human Development, he has led its exercise physiology program. Curry School Dean Robert Pianta appointed him the founding chair of the new Department of Kinesiology in 2013.

He also founded and directs the Exercise Physiology Core Laboratory, funded by the National Institutes of Health for 30 years, and holds a joint appointment in the School of Medicine. Weltmans research focuses on the role of intense and regular exercise in health and disease. He and his collaborators have contributed to understanding how exercise affects individuals from children to older adults.

Through his exercise physiology courses, he has influenced thousands of graduate and undergraduate students and trained scientists in exercise intervention. His students engage in the exercise research as participants as well as investigators. They have written about how much they learn in his challenging classes and how much they appreciate his laid-back approach and availability.

Weltman also helped to initiate both peer and alumni mentoring programs, and he continues to serve as a resource for students long after they graduate. Many have gone on to academic careers and point to his mentorship for influencing their success.

Recognized by the Seven Society and the Z Society for his passion and devotion to teaching at the University, Weltman wrote that the opportunity to teach and learn from students in and outside of the classroom is one of the joys of my job and among the most rewarding experiences of my career.

The opportunity to teach and learn from students in and outside of the classroom is one of the joys of my job and among the most rewarding experiences of my career.

- Arthur Weltman

He added that he is both honored and humbled to be named a recipient of this prestigious award. From my perspective, this award is a testament to the talented students, faculty and staff who I have had the pleasure of working with over the last 35 years at UVA, he wrote in an email about the SCHEV award.

His research is known nationally and internationally. The NIH has funded his research projects, many with cross-disciplinary collaborators and students, for more than 30 years. He has published 246 papers in refereed journals at last count, many with student co-authors, and his work has an exceptionally high rate of citation by other researchers.

Some of the topics he and colleagues have studied include whether strength training is safe and effective for prepubescent children, and how high-intensity exercise affects growth hormone release or cardiometabolic risk in older adults.

He has served as an exercise physiology adviser for the Department of Athletics at UVA since 1990, as well as for a number of professional sports teams.

Go here to see the original:
UVA, UVA-Wise Land Three Professors Among State's Top 12 for 2020 - University of Virginia

STUDENTS OF THE MONTH – Wicked Local Chelmsford

Tierney named student of the month

Whittier House announced Natalie Tierney, daughter of Gregory Tierney and Laura Tierney, as student of the month for November. Natalie is currently enrolled in AP Statistics, AP Literature and Composition, AP Music Theory, AP Calculus BC, Programming, Honors Band, and Nutrition. Natalie is a dedicated student and a great representation of both Whittier House and Chelmsford High School.

Natalie, also known as Nat to her softball peers, has achieved many accolades in the classroom. Nat has earned membership into the National Honor Society, National English Honor Society and the Spanish Honor Society. She has reached High Honor Roll status all through her years at CHS. She has been recognized as an Emerging Leader two years in a row. She has been selected, based on highest GPA in the program, as the Scholar Athlete for both the Varsity Basketball and Varsity Softball teams. Nat has also been recognized by the John Philip Sousa National High School Honors Band and earned recognition as a Book Scholar Award recipient her junior year.

The tremendous work Nat has accomplished in the classroom is matched with exemplary work outside of the classroom. Nat is a member of the Marching Band, Pit Orchestra, Varsity Basketball and Varsity Softball teams, a Freshman Mentor and an active member in LIME. Nat is also the Flute Section Leader in the band.

Outside of CHS, Nat volunteers and works many hours. Her community service includes the local bottle and can drive, Chelmsford Public Library Book Drive, and volunteering at the CHS Girls basketball and softball camps. Nat works as an employee for Community Education during the school year and through the summer. In her free time Nat enjoys playing the flute, painting, reading, being outdoors and spending time with family and friends.

Next year Natalie plans to attend college and major in math and/or computer science with a minor in music, entering the field of mathematics after receiving a degree. Whatever the future holds for Nat, I am sure that she will continue to have a smile on her face and embrace any obstacles or challenges that she encounters. Whittier House sincerely wishes Nat the best of luck and continued success in the future.

Chaudhary named student of the month

Whittier House announced Aaryan Chaudhary, son of Ashish Chaudhary and Archana Chaudhary, as student of the month for November. Aaryan is currently enrolled in AP Calculus AB, AP English Literature and Composition, AP Computer Science Principles, AP Psychology, Anatomy and Physiology Honors, Introduction to Engineering and Design, and The Power of Choice.

Aaryan is a very successful student at CHS and major contributor to the school culture. As a result of his fantastic work in the classroom, Aaryan has earned membership into the National Honor Society, National English Honor Society and The National French Honor Society. Aaryan has also achieved AP Scholar status, High Honor Roll for all terms at CHS, and was recognized as an Emerging Leader from Whittier House in the Spring of 2019.

Aaryans work in the classroom is almost unmatched, but his work outside of the classroom truly makes CHS a better place. Aaryan is on the Freshman Mentor Board, a member of the Interact Club, DECA, Math Team, Science Team and a very active member of Class Reps. His work and dedication in all of these extra-curricular areas has resulted in Aaryan being a leader and great representation of what CHS has to offer. Aaryan was also chosen to represent Chelmsford with a group of his peers at the RYLA Leadership Summer Camp during the summer following his 10th grade year.

Aaryan stays very active outside of CHS. He is almost a decade-long participant in Taekwondo, which has resulted in him earning a third-degree black belt. He is a scooper at the recently opened Trailside Ice Cream in Chelmsford Center and a mentor at Code Academy for young aspiring coders.

Aaryan plans on studying Biomedical Engineering with the hopes of earning an undergraduate degree with the possibility of pursuing a PhD in the field. He also plans to continue to serve his community.

Whittier House is very excited to see what the future has in store for Aaryan. We wish him the best of luck during the remainder of his senior year and beyond.

LaCava named student of the month

Hawthorne House announced that Emma LaCava has been selected as the student of the month for November. Emma is the daughter of Jessica and Michael LaCava. Emma has been an outstanding academic and fine art related student at Chelmsford High School.

This year, Emma is enrolled in a variety of challenging courses at Chelmsford High School including AP English Literature, Honors Band, Calculus, AP Psychology, Physics, Nutrition, and Sociology. During her high school years, she has maintained High Honor Roll every term and is a member of the National Honor Society, the Spanish Honor Society, and the National English Honor Society.

Emma has been an active member of our theater, music, and fine art programs at Chelmsford High School. She has made a deep and lasting impact on these programs throughout her time at Chelmsford High School and these programs for years to come. Emma has been extremely active in the CHS Marching Band serving as the Drum Major for both her junior and senior years. Through her work with the Theatre Guild she has served as the Assistant Student Producer last year and the Student Producer this year. Her passionate investment in the Theater program for countless shows over the past four years in nearly every role has enriched and enlivened each production. Emma is also a member of the CHS Jazz Band, All Town Wind Ensemble, and serves as the student reporter to the Chelmsford High School Alumni Association. Emma is one of the most talented, creative, and passionate students we currently have at Chelmsford High School. She clearly balances her passion for the Fine Arts with her academic achievements.

Outside of school, Emma volunteers her talents as a Sunday School teacher at the Grace Community Church and has worked with kids in the after-school programs at both the Center Elementary and South Row Elementary Schools. It is evident that Emma gives of herself selflessly and whole heartedly to whichever activity she is involved.

Emma plans to major in either Business or Business Administration and hopes to attend either Northeastern University, Bentley University, or American University next fall. In the future, Emma hopes to work as an Event Planner and dreams of owning her own business planning private events. Emmas passion coupled with her wonderful personality and work ethic will undoubtedly make her an extraordinary success. It is with great confidence that Chelmsford High School can state that Emma will leave a lasting impact when she takes her talent, passion, and enthusiasm to her school next year.

Hawthorne House and Chelmsford High School are proud to have Emma LaCava as our Student of the month and we are confident she will succeed in anything she decides to pursue.

Boles named student of the month

Hawthorne House announced that Chase Boles has been selected as the student of the month for November. Chase is the son of Deborah and Randall Boles. Chase has been an outstanding academic and fine art related student at Chelmsford High School.

This year, Chase is enrolled in a variety of challenging courses at Chelmsford High School including AP English, AP Spanish, AP Calculus, AP Environmental Science, Common Law and Trial Procedures, and an independent study in English Dialectology and Accentology. During his high school years, he has maintained High Honor Roll every term and is a member of the National Honor Society, the National English Honor Society, the Spanish Honor Society, and is a National Merit Scholarship Semi-Finalist.

Chase has been an active member of our theater, music, and fine art programs at Chelmsford High School. He has made a profound impact on these programs throughout his time at Chelmsford High School and will leave as one of the most decorated actors/singers/performers in school history. He has been a three -year member of the nationally recognized a Capella group The Thursdays. Chase has been integral to the groups success through his vocal and arranging talents helping the group make it to Nationals the last three years and placing 3rd overall last year! Chase has also been passionately involved in the CHS Musical over the past four years landing important roles in Into the Woods, Anything Goes, Fiddler on the Roof, and this years production of Chicago. Chase was also nominated for Best Supporting Actor for his portrayal of Leaf Coneybear in the 25th Annual Putnam County Spelling Bee for METG. In addition to these commitments, Chase is a member of the Vocal Jazz Ensemble, L.I.M.E, Deans Council, and Middlesex Community College Childrens Theater. Chase is one of the most talented, creative, and passionate students we currently have at Chelmsford High School. He clearly balances his passion for the Fine Arts with his academic achievements.

Outside of school, Chase gives selfishly of himself to his community. He has volunteered as a piano accompanist at the Paul Center, with the Chelmsford Friends of Music, and at the Savoy Light Opera Company in Carlisle. Chase gives of himself selflessly and whole heartedly to whichever activity he is involved. Yet what sets Chase apart is his natural empathy and kindness. Chase makes those with whom he has contact the better for it!

Chase plans to major in Linguistics/Anthropology and Applied Mathematics and hopes to attend either Brown University, McGill University or Wesleyan University. Chase hopes to join the Peace Corps in Vietnam after college, attend graduate school, and eventually become a college professor. Those who know Chase do not doubt him in the slightest! It is with great confidence that Chelmsford High School can state that Chase will be a tremendous addition to a fortunate college in the fall when he takes his talent, passion, and enthusiasm to his school next year.

Hawthorne House and Chelmsford High School are proud to have Chase Boles as our Student of the month and we are confident he will succeed in anything he decides to pursue.

Estafanous named student of the month

Emerson House announced Boula Estafanous, son of Emad Estafanous and Marian Estafanous, as student of the month for November. Boula is an exceptional student at Chelmsford High School and is currently engaged in a rigorous set of classes. He is taking five Advanced Placement courses as a senior. These AP classes include Chemistry, Calculus, Psychology, Statistics, and Literature & Composition. Along with these courses, Boula is also taking Honors Anatomy & Physiology and Principles of Engineering. His dedication to his studies and extracurricular activities is amazing and commendable. Boula is a great representation of both Emerson House and Chelmsford High School.

Boula is a very talented student and leader who is well respected and regarded at Chelmsford High School. Academically, Boula is a consistent High Honor Roll student, maintaining an impressive 4.076 GPA. He is a member of four different honor societies at Chelmsford High School. These include, the National Honor Society, the Spanish Honor Society, the National English Honor Society, and the newly formed Science National Honor Society. Along with his amazing academic accomplishments, Boula is involved in a variety of athletic and civic clubs at Chelmsford High School. He is a Freshman Mentor, a member of the GIVE, Journey, Interact, Key and Badminton Clubs. Additionally, he is a member of the Thomas Jefferson Forum Board. Boula is extremely dedicated to his family and his church. He is a Deacon at his church and a St. Mark Winter Camp Counselor. This past summer, he opted to forgo an amazing internship opportunity at UMASS Lowell in order to work to help support his family. This tremendously selfless young man loves his family and parents. Boula and his family moved to Chelmsford from Egypt when he was in the fourth grade. His long-term goal is to help his parents retire.

Boula is a highly motivated and dedicated student who has earned his recognition as a top Emerson student. He has plans to attend Tufts or Brown next fall and study Biomedical Engineering. Boula is fluent in 3 languages, English, Arabic and Spanish. He can read and write Coptic and is highly dedicated to his faith. He also enjoys biking, swimming, and playing soccer. Boula is an impressive individual and we wish him continued success.

Adams named student of the month

Emerson House announced Jasmine Adams, daughter of Angelo Adams and Donna Adams, as student of the month for November. Jasmine is currently enrolled in many rigorous courses, including three Advanced Placement courses. These AP courses include Psychology, Computer Science, and Calculus AB. Additionally, Jasmine is taking Anatomy & Physiology, Senior Odyssey, Digital Filmmaking, and Common Law & Trial Procedures II. Jasmine is one of the highest ranked students in the school and has proven herself as a leader. Her impressive achievements, both in and out of the classroom, make her an obvious choice for Emerson Student of the month.

Jasmine Adams is a highly intelligent, hardworking, personable and ambitious young woman who has a very impressive resume. Jasmine embodies many great qualities. She is a scholar, an athlete, and a leader. Academically, Jasmine has excelled earning some amazing accolades, including membership into the National Honor Society, Spanish Honor Society and the English Honor Society. This consistent High Honor Roll student has also been a standout track athlete. A member of both the Indoor and Outdoor Track teams, Jasmine is a state qualifying relay runner and high jumper. Her track accomplishments have led to her receiving 2nd Team All Conference awards. In addition to her academic and athletic achievements, Jasmine is highly involved in a variety of extracurricular activities at CHS, demonstrating amazing leadership qualities. She is a member of the Interact Club, Thomas Jefferson Forum, Deans Council, and is a Freshman Mentor. Additionally, Jasmine is a volunteer, dedicating her time to her church and the Chelmsford Public Library. She also is an assistant teacher and member of the Studio A Dance Company and the videographer for Chelmsford Pop Warner Football.

Jasmine Adams is an exceptional student and while Chelmsford High will experience a void upon her departure. Jasmine has aspirations of majoring in Biomedical Engineering and is considering attending West Point and has already received an offer to attend the Naval Academy. This past summer, Jasmine attended the Harvard Summer Pre-College Program and Leadership Summits at both West Point and the Air Force Academy. Jasmine is a dedicated student, continuously creating goals for herself that she not only meets, but far surpasses. We wish her continued success in all her future endeavors.

Read more:
STUDENTS OF THE MONTH - Wicked Local Chelmsford

2019 Best of Design Awards winners for Healthcare – The Architect’s Newspaper

2019 Best of Design Award for Healthcare: University of Cincinnati Gardner Neuroscience InstituteDesigner: Perkins and WillLocation: Cincinnati

The University of Cincinnati Gard- ner Neuroscience Institute is a leading treatment, research, and teaching center for complex neurological conditions. Each component of this patient-centered facility was developed with user input. Shaped through input from Perkins and Wills Human Experience Lab, the design responds to patients specific needs at every step of their journeys. The facade is wrapped in a tensile mesh that reduces glare for patients while improving energy performance and giving the building a distinctive look. Patient comfort is prioritized with the protective facade, wheelchair-friendly sliding doors, and flexible seating for staff, patients, and family members. Simplified circulation and plentiful daylight assist wayfinding, while a comfortably scaled lobby creates a calming entry experience.

General Contractor: Messer ConstructionMechanical and Electrical Engineer: Heapy EngineeringCivil Engineer: The Kleingers GroupStructural Engineer: Shell + Meyer AssociatesConstruction Manager: Hplex Solutions

Honorable Mentions

Project Name:Duke University Student Wellness CenterDesigner: Duda|Paine Architects

Healthcare: Duke University Student Wellness Center (Robert Benson Photography)

Project Name:MSK NassauDesigner: EwingCole

Healthcare: Honorable Mention: MSK Nassau (Courtesy EwingCole)

Editors Picks

Project Name:Samson Pavilion, CWRU and Cleveland ClinicDesigner: Foster + Partners

Project Name:Tia ClinicDesigner: Rockwell Group

Read the rest here:
2019 Best of Design Awards winners for Healthcare - The Architect's Newspaper

Neuroscience Market Size & Share Analysis in terms of value & volume by 2025 – The Industry Press Releases

A leading research firm, Zion Market Research added a latest industry report on "Global Neuroscience Market" consisting of 110+ pages during the forecast period and Neuroscience Market report offers a comprehensive research updates and information related to market growth, demand, opportunities in the global Neuroscience Market.

According to the report the Neuroscience Market Size & Share Analysis in terms of value & volume by 2025

The Neuroscience Market report provides in-depth analysis and insights into developments impacting businesses and enterprises on global and regional level. The report covers the global Neuroscience Market performance in terms of revenue contribution from various segments and includes a detailed analysis of key trends, drivers, restraints, and opportunities influencing revenue growth of the global consumer electronics market.This report studies the global Neuroscience Market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Neuroscience Market by companies, region, type and end-use industry.

Request a Free Sample Report on Neuroscience Market:https://www.zionmarketresearch.com/sample/neuroscience-market

The Neuroscience Market report mainly includes the major company profiles with their annual sales & revenue, business strategies, company major products, profits, industry growth parameters, industry contribution on global and regional level.This report covers the global Neuroscience Market performance in terms of value and volume contribution. This section also includes major company analysis of key trends, drivers, restraints, challenges, and opportunities, which are influencing the global Neuroscience Market. Impact analysis of key growth drivers and restraints, based on the weighted average model, is included in this report to better equip clients with crystal clear decision-making insights.

The Neuroscience Market research report mainly segmented into types, applications and regions.The market overview section highlights the Neuroscience Market definition, taxonomy, and an overview of the parent market across the globe and region wise.To provide better understanding of the global Neuroscience Market, the report includes in-depth analysis of drivers, restraints, and trends in all major regions namely, Asia Pacific, North America, Europe, Latin America and the Middle East & Africa, which influence the current market scenario and future status of the global Neuroscience Market over the forecast period.

Get Free PDF Brochure of this Report: https://www.zionmarketresearch.com/requestbrochure/neuroscience-market

The Neuroscience Market report provides company market size, share analysis in order to give a broader overview of the key players in the market. Additionally, the report also includes key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product and regional expansion of major participants involved in the market on the global and regional basis.

Major Company Profiles Covered in This Report:

Alpha Omega, Axion Biosystems, Blackrock Microsystems LLC, Femtonics Ltd., Intan Technologies, LaVision Biotec GmbH, Mediso Medical Imaging Systems, Neuralynx Inc., NeuroNexus Technologies, Neurotar Ltd., Newport Corporation, Plexon Inc., Scientifica Ltd., Sutter Instrument Corporation, Thomas Recording GmbH, and Trifoil Imaging Inc.

Some of the major objectives of this report:

1) To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Neuroscience Market.

2. To provide insights about factors affecting the market growth. To analyze the Neuroscience Market based on various factors- price analysis, supply chain analysis, porter five force analysis etc.

3. To provide historical and forecast revenue of the Neuroscience Market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World.

4. Country level analysis of the market with respect to the current market size and future prospective.

5. To provide country level analysis of the market for segment by application, product type and sub-segments.

6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.

7. Track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Neuroscience Market.

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the clients needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to usafter allif you do well, a little of the light shines on us.

Contact Us:

Zion Market Research

244 Fifth Avenue, Suite N202

New York, 10001, United States

Tel: +49-322 210 92714

USA/Canada Toll Free No.1-855-465-4651

Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Sorry! The Author has not filled his profile.

The rest is here:
Neuroscience Market Size & Share Analysis in terms of value & volume by 2025 - The Industry Press Releases

Neuroscience Antibodies and Assays Market Survey Report 2019 Along with Statistics, Forecasts till 2025 – Daily Research Reporting

Global Neuroscience Antibodies and Assays Market Size, Status and Forecast 2019-2025

The report titledNeuroscience Antibodies and Assays Markethas recently added byMarketInsightsReportsto get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts.

Get Free Sample Copy of this Report:

https://www.marketinsightsreports.com/reports/06251317412/global-neuroscience-antibodies-and-assays-market-size-status-and-forecast-2019-2025/inquiry?source=dailyresearchreporting&Mode=07

Top Leading Companies of Global Neuroscience Antibodies and Assays Market are: Thermo Fisher, Abcam, Bio-Rad, Merck, Cell Signaling Technology, Genscript, Rockland Immunochemicals, BioLegend, Santa Cruz Biotechnology, Roche, Siemens and others.

This report segments the global Neuroscience Antibodies and Assays market on the basis of Types are:

Consumables

Instruments

On the basis of Application, the Global Neuroscience Antibodies and Assays market is segmented into:

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Hospitals & Diagnostic Centers

Neuroscience Antibodies and Assays Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report. The report contains basic, secondary and advanced information pertaining to the Neuroscience Antibodies and Assays Market global status and trend, market size, share, growth, trends analysis, segment and forecasts from 2019-2025.

Explore Full Report With Detailed TOC Here:

https://www.marketinsightsreports.com/reports/06251317412/global-neuroscience-antibodies-and-assays-market-size-status-and-forecast-2019-2025?source=dailyresearchreporting&Mode=07

Detailed overview of Neuroscience Antibodies and Assays Market Changing Neuroscience Antibodies and Assays market dynamics of the industry In-depth market segmentation by Type, Application etc. Historical, current and projected Neuroscience Antibodies and Assays market size in terms of volume and value Recent industry trends and developments Competitive landscape of Neuroscience Antibodies and Assays Market Strategies of key players and product offerings Potential and niche segments/regions exhibiting promising growth.

The research includes historic data from 2014 to 2019 and forecasts until 2025 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts and stakeholders looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Finally, Neuroscience Antibodies and Assays Market report is the believable source for gaining the market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request and market development rate and figure and so on. Neuroscience Antibodies and Assays industry report additionally Present new task SWOT examination, speculation attainability investigation, and venture return investigation.

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Irfan Tamboli (Head of Sales) Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

sales@marketinsightsreports.com | irfan@marketinsightsreports.com

See original here:
Neuroscience Antibodies and Assays Market Survey Report 2019 Along with Statistics, Forecasts till 2025 - Daily Research Reporting

Neuroscience Market Overview, Growth Impact and Demand by Regions till 2026 – Galus Australis

Coherent Market Insights released a new market study on the 2018-2026 Neuroscience Marketwith 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry-validated market data. Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The research study provides estimates for the 2018-2026 Neuroscience Market Forecast till 2026*.

Synopsis Research Report covers insights into the Neuroscience industry over the past five to eight years and forecasts until 2018-2026. The Market report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Market 2018 Industry Trend and Forecast 2026

The report provides key statistics on the market status of the manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. The Market report also presents the vendor landscape and a corresponding detailed analysis of the major vendors operating in the market.

Get Sample Demo PDF Here: https://www.coherentmarketinsights.com/insight/request-pdf/2487

Regional Analysis:

North America: United States, Canada, MexicoEurope: Germany, France, UK, Russia, Italy, Rest of EuropeMiddle East Africa: Turkey, Egypt, South Africa, GCC Countries, Rest of Middle East & AfricaAsia-Pacific: India, Australia, Japan, China, South Korea, Indonesia, Malaysia, Philippines, Thailand, Vietnam

Global Key Players: Alpha Omega, Inc., GE Healthcare, Axion Biosystems, Inc., Siemens Healthineers, Blackrock Microsystems LLC, Femtonics Ltd., Intan Technologies, LaVision Biotec GmbH, Mediso Medical Imaging Systems, Neuralynx Inc., NeuroNexus Technologies, Inc., Newport Corporation, Plexon Inc., Noldus Information Technology, Scientifica Ltd., Sutter Instrument Corporation, Thomas Recording GmbH, and Trifoil Imaging Inc.

In the end, the report makes some important proposals for a new project of this Industry before evaluating its feasibility. Overall, the report provides an in-depth insight into the global NeuroscienceMarketcovering all important parameters.

Neuroscience Driver Neuroscience Challenge Neuroscience Trends

Further, in the research report, the following points are included along with an in-depth study of each point:

Production Analysis Production is analyzed with respect to different regions, types, and applications. Here, the price analysis of various Market key players is also covered.

Sales and Revenue Analysis Both, sales and revenue are studied for the different regions of the global market. another major aspect, price, which plays an important part in the revenue generation is also assessed in this section for the various regions.

Supply and Consumption In continuation of sales, this section studies the supply and consumption of the Market. This part also sheds light on the gap between supply and consumption. Import and export figures are also given in this part.

Other analyses Apart from the information, trade and distribution analysis for the Market, contact information of major manufacturers, suppliers and key consumers are also given. Also, SWOT analysis for new projects and feasibility analysis for new investment are included.

In continuation with this data, the sale price is for various types, applications and regions are also included. The Market for major regions is given. Additionally, type wise and application wise consumption figures are also given.

Few Necessary Concerns Covered In The Report:

Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/2487

In this study, the years considered to estimate the market size are as follows:

History Year: 2015-2017Base Year: 2017Estimated Year: 2018Forecast Year 2018 to 2026

For More Related Reports Visit This Blog:https://globalhealthcareinsights.wordpress.com/blog

Originally posted here:
Neuroscience Market Overview, Growth Impact and Demand by Regions till 2026 - Galus Australis

Neuroscience grad has research on the brain | ANU Science, Health & Medicine – Science at ANU

When you ask Ayla Venslovas about her fondest memory from her Master of Neuroscience at ANU, she says, without hesitation: doing the assignments.

This might sound like the kind of thing you say only after your assignments are all behind you and youre ready to graduate, but Ayla actually felt this way at the time too. In fact, she loved the neuroscience research essay subject so much, she did it twice.

When you start researching a topic, it's overwhelming because there are hundreds of papers to read, she admits. But when you get to the towards the end of your research, you're really able to critically evaluate what you've done and what other people have done, and then all of a suddenthere it is! You see what it is that youre trying to find and it all comes together.

Its so rewarding because you put so much effort into it, and then it just clicks.

Aylas research papers were on how retinal cells communicate with each other, and glutamate recycling in the brain. The opportunity to have completed this complex research is part of the reason she says shell be graduating from her masters program with confidence in her expertise in the field.

The other, she says, is that she was treated not as a student, but a colleague, by the academics at the John Curtin School of Medical Research.

It's exciting when youre in the labs and you hear two scientists talking about something and you realise you understand what theyre saying.

Being around all the research, in that kind of environment, just feels smart.

Ayla says she was drawn to neuroscience because of the complexity of the nervous system. Trying to understand it, she says, is like unravelling a big knot.

I studied medical science as an undergrad, and even then, I always kept going back to the brain. I just wanted to know more about it, because it makes you who you are. All our individual nuances are in there.

Studying the brain has changed her perspective on her own, too, Ayla says.

Like many people, I have anxiety so it's kind of nice knowing what's going on in there, on that fundamental level when Im getting that physiological response to it.

It helps me talk myself down from the anxiety, to know that as emotional as it feels, its all in the brain.

When it comes to emotions, Ayla says shes conflicted in her feelings about graduation.

Im excited, yes, but Im also a bit sad that its over. If I could do this masters forever, I would do it.

And it doesnt sound like just something you say.

Find out more about how a Master of Neuroscience at ANU can help unravel the mysteries of the brain. It usually takes two years to complete, even if you never want it to end.

Continue reading here:
Neuroscience grad has research on the brain | ANU Science, Health & Medicine - Science at ANU